Analytical Phase of Diagnostic Testing – Quality Control & ISO 15189

Review of Previous Lecture and Context

  • The lecturer (Youping) greets the audience and reminds them:
    • Last lecture focused on Pre-Analytical Phase of the Total Testing Process (TTP).
    • Emphasized that pre-analytical steps account for the majority of testing errors.
  • Current lecture objective: step forward to the Analytical Phase.
    • Guiding questions:
    • What is the analytical phase and how is it distinct from the pre-analytical phase?
    • How do labs evaluate quality during the analytical phase?
    • How are Internal Quality Control (IQC) and External Quality Assurance (EQA) implemented?
    • Which statistical rules (e.g., Westgard rules) determine run acceptance/rejection?
    • How does one read a Levey–Jennings control chart and interpret EQA reports?

Total Testing Process (TTP) – Placement of Analytical Phase

  • TTP begins with a clinical question and ends with a diagnostic action.
  • Pre-Analytical Phase:
    • Many intermediate processes outside the lab (patient prep, specimen collection, transport, accessioning).
    • Accounts for the vast majority of errors (≈ 70\% of unexpected or erroneous results).
  • Analytical Phase (today’s focus):
    • Activities performed inside the laboratory.
    • Starts with analytical quality design.
    • Goal: assure/ improve measurement quality and reliability.
    • Error contribution relatively low: only ≈ 10\text{–}15\% of total mistakes.

Improving Analytical Quality

  • Automation
    • Modern laboratories deploy automated lines and robotic sample handlers.
    • Benefits:
    • Repeatability & consistency.
    • Reduced human variability → decreased error rate.
    • Illustrated by a schematic of a laboratory automation system.

Common Analytical Phase Errors

  • Undetected IQC failure
  • Instrument / equipment malfunction
    • E.g., probe clogs, hardware wear-out.
  • Sample probe failure → mis-identification, mix-up
  • Analytical interference
    • Endogenous: hemolysis, lipemia, icterus, paraproteins.
    • Exogenous: medication, anticoagulants, contaminants.
  • Scope limitation of this lecture: focus on Quality Control (QC) only (other errors to be covered separately).

Quality Control & Quality Assurance Framework

  • Internal Quality Control (IQC)
    • Routine checking of analytical run validity.
    • Uses control materials with known target ranges.
    • Results plotted on Levey–Jennings charts.
  • External Quality Assurance (EQA / Proficiency Testing)
    • Inter-laboratory comparison.
    • Periodic, blind samples sent by a scheme provider.
    • Lab receives performance report and peer group statistics.
  • Statistical Decision Rules: Westgard Rules
    • Provide acceptance/rejection criteria for daily runs.
    • Examples (not yet elaborated here): 1_2s, 1_3s, 2_2s, R_4s, 4_1s, 10_x.

Regulatory & Standards Landscape

1. Clinical and Laboratory Standards Institute (CLSI)

  • Global, non-profit, consensus-based organisation.
  • Develops best-practice guidelines for:
    • Sample types: blood, body fluids (urine, saliva, CSF), tissues, hair, etc.
    • Technical procedures, QC, QA, safety, informatics.
  • Recognised by labs, accreditors, regulators worldwide.

2. National Association of Testing Authorities (NATA) – Australia

  • Provides accreditation for:
    • Clinical laboratories, inspection bodies.
    • Calibration services, reference material producers.
    • Proficiency testing scheme providers.
  • Broader scope beyond healthcare: food, construction, environment.
  • Endorsed by Australian Government as benchmark for “better regulation, good governance & fair markets.”

3. International Organization for Standardization (ISO) – Standard 15189

  • ISO = worldwide federation of national standards bodies.
  • ISO 15189: “Medical laboratories – Requirements for quality and competence.”
    • Prepared by Technical Committee on clinical lab testing & in-vitro diagnostics.
  • Publication timeline:
    • 1st edition: 02/2003.
    • 3rd/current edition: 2012 (still in use).
  • Purpose & scope:
    • Sets QMS requirements tailored to medical laboratories.
    • Helps labs self-assess competence & seek accreditation.
    • Universal: applies to any division or organisational structure of a medical lab.
  • Core goals:
    • Develop failure-resistant environment – detect mistakes early.
    • Continuous quality improvement through staff empowerment & process optimisation.

ISO 15189 Structure

  • Divided into 2 main parts:
    1. Management Requirements (QMS focus)
    • Regular management reviews.
    • Scheduled internal audits.
    • Objective: ensure activities remain effective & meet client needs.
    • Foster culture of proactive improvement (identify opportunities before issues arise).
    • Example components (left column of lecture table):
      • Quality policy & objectives.
      • Document control.
      • Contract review.
      • Corrective & preventive actions.
    1. Technical Requirements (competence focus)
    • Personnel qualifications & training.
    • Method validation/verification.
    • Equipment calibration & maintenance.
    • Pre-examination, examination, post-examination processes.
    • Measurement uncertainty, traceability.

Laboratory Duties Under ISO 15189 (summarised from slide)

  • Maintain comprehensive policies and Standard Operating Procedures (SOPs).
  • Ensure all staff are trained & competent in technical, quality-management, and clinical tasks.
  • Instrument performance must be documented:
    • Calibration schedules.
    • Maintenance logs.
    • QC statistics.
  • Environmental monitoring:
    • Incubator temp/humidity.
    • Refrigerator/freezer temps.
    • Logbooks for verification & alarms.

Key Take-Home Points

  • Analytical phase contributes smaller error proportion but still requires rigorous QC.
  • Automation enhances consistency yet cannot replace formal QC/QA systems.
  • Implementation of IQC, EQA, Westgard rules, and Levey–Jennings charts are core to error detection during analysis.
  • CLSI, NATA, ISO 15189 provide layered governance ensuring labs deliver reliable, competent diagnostic services.
  • Building a failure-resistant environment entails proactive monitoring, staff empowerment, and continual quality improvement.

Upcoming Content (Teaser)

  • Detailed walkthrough of:
    • Westgard rule interpretation.
    • Levey–Jennings chart diagnostics (shift, trend, random error detection).
    • Reading & acting on EQA proficiency reports.
  • Expanded discussion on analytical interferences and troubleshooting strategies.